I’m a CLL patient and my question relates to CRISPR, the gene editing tool. How soon with this become a reality in the treatment of leukemia and other blood cancers? - by Barry G from USA Topics: CAR T Therapy, CLL (Chronic Lymphocytic Leukemia, CRISPR, diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), gene editing tool, genetic therapy, multiple myeloma (MM), mutation, sickle cell disease (SCD), T cells View Answer
